Promises, Deceit and White-Collar Criminality Within the Theranos Scandal
Theranos rose to prominence by selling a dream that a company could make blood testing less painful and more effective. The company strove to bring new technology to the laboratory industry that would make Americans healthier. After securing more than $700 million from investors, Theranos would even...
Saved in:
| Published in | Journal of white collar and corporate crime Vol. 3; no. 2; pp. 109 - 121 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | English |
| Published |
Los Angeles, CA
SAGE Publications
01.06.2022
Sage Publications Ltd |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Theranos rose to prominence by selling a dream that a company could make blood testing less painful and more effective. The company strove to bring new technology to the laboratory industry that would make Americans healthier. After securing more than $700 million from investors, Theranos would eventually receive, at its height, a $9 billion company valuation. As it turned out, Theranos and its founder, Elizabeth Holmes, had mainly promised innovations predicated on proprietary technology that did not work. Eventually, Holmes, and former company president Ramesh Balwani, would be charged with fraud both by the SEC and the federal government. The Theranos scandal has multiple dimensions that make it an interesting case study for white-collar and corporate crime. |
|---|---|
| AbstractList | Theranos rose to prominence by selling a dream that a company could make blood testing less painful and more effective. The company strove to bring new technology to the laboratory industry that would make Americans healthier. After securing more than $700 million from investors, Theranos would eventually receive, at its height, a $9 billion company valuation. As it turned out, Theranos and its founder, Elizabeth Holmes, had mainly promised innovations predicated on proprietary technology that did not work. Eventually, Holmes, and former company president Ramesh Balwani, would be charged with fraud both by the SEC and the federal government. The Theranos scandal has multiple dimensions that make it an interesting case study for white-collar and corporate crime. |
| Author | Griffin, O. Hayden |
| Author_xml | – sequence: 1 givenname: O. Hayden surname: Griffin fullname: Griffin, O. Hayden email: hgriffin@uab.edu organization: , AL, USA |
| BookMark | eNp1kM1LAzEQxYNUsNbePQa8upqv3SRHWb8KBQUr9baM6dRN2W5qsj30v3dLFUHwNMPM7w3z3ikZtKFFQs45u-Jc62tRSC6ZfRPM5tJIcUSG-1EmOZODn77fn5BxSivGmMg5V8YMyeQ5hrVPmC7pLTr0HYV2Qee17zArQ9NApGX0a99C47sdnfuu9i3taqSzGiO0IdEX10ugOSPHS2gSjr_riLze383Kx2z69DApb6aZ47kSWQEcITdaGaEVCACbawOFgAXm2lmjDAOn3_eEK4xCizkWTmjtNC8sajkiF4e7mxg-t5i6ahW2sf8vVb1FrZSyUvQUO1AuhpQiLqtNbwPiruKs2mdW_c2sl2QHSYIP_D36L_8FnkBrUg |
| CitedBy_id | crossref_primary_10_1080_14680777_2023_2245979 crossref_primary_10_1177_25151274211022282 |
| Cites_doi | 10.1177/0002716293525001002 10.1172/JCI86318 10.2307/1189727 10.1002/j.2325-8012.2007.tb00827.x 10.7326/0003-4819-122-6-199503150-00009 10.1111/j.1747-4469.1996.tb00093.x 10.1007/s10612-010-9113-9 10.1046/j.1440-1843.2003.00516.x 10.1038/nm1017-1114 10.13169/statecrime.3.2.0237 10.2307/2083937 10.1111/hojo.12116 10.1177/0022042612467990 10.1093/oso/9780195070705.001.0001 10.2307/2393390 10.1515/9781400860326 10.1080/07418828600088891 10.1080/01459740.1982.9987019 10.2307/3479500 10.1177/2631309X19882641 10.1016/0277-9536(93)90144-S 10.1017/S0022050700109933 10.2105/AJPH.66.12.1202 10.4337/9781783471102 10.2307/3097160 10.1007/s10611-016-9634-6 10.5204/ijcjsd.v6i4.447 10.1093/oso/9780195125092.001.0001 10.1001/jama.2013.286274 10.1080/13598139.2017.1302874 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2020 |
| Copyright_xml | – notice: The Author(s) 2020 |
| DBID | AAYXX CITATION K7. |
| DOI | 10.1177/2631309X20953832 |
| DatabaseName | CrossRef ProQuest Criminal Justice (Alumni) |
| DatabaseTitle | CrossRef ProQuest Criminal Justice (Alumni) |
| DatabaseTitleList | ProQuest Criminal Justice (Alumni) CrossRef |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Social Welfare & Social Work |
| EISSN | 2631-3103 |
| EndPage | 121 |
| ExternalDocumentID | 10_1177_2631309X20953832 10.1177_2631309X20953832 |
| GroupedDBID | .2L 0R~ 1~K 31W 31X 54M 56W AADIR AATAA ABFXH ABJNI ABPNF ABQPY ABQXT ACFUR ACFZE ACLZU ACOXC ACSIQ ACUIR ADRRZ ADTOS AEDXQ AESZF AEVPJ AEWHI AFKRG AFMOU AFQAA AGDVU AGKLV AGNWV AHWHD AIOMO AJUZI ALMA_UNASSIGNED_HOLDINGS ANDLU ARTOV AYPQM B8T B8Z BPACV DG~ DV7 DV8 EBS FHBDP GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION H13 J8X JCYGO M4V Q7P ROL SAFTQ SCNPE SFC SFK SFT SGU SGV SHB SPP AAYXX ACJER CITATION K7. |
| ID | FETCH-LOGICAL-c1542-6a1ea58748274a2aa9578a62ade57c98480ac7b5874c684e9e5e6c277c7169e73 |
| ISSN | 2631-309X |
| IngestDate | Thu Oct 10 22:03:59 EDT 2024 Fri Dec 06 07:33:19 EST 2024 Sun Aug 25 05:40:13 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | white collar crime corporate crime business crime |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c1542-6a1ea58748274a2aa9578a62ade57c98480ac7b5874c684e9e5e6c277c7169e73 |
| PQID | 3097444932 |
| PQPubID | 7030804 |
| PageCount | 13 |
| ParticipantIDs | proquest_journals_3097444932 crossref_primary_10_1177_2631309X20953832 sage_journals_10_1177_2631309X20953832 |
| PublicationCentury | 2000 |
| PublicationDate | 20220600 2022-06-00 20220601 |
| PublicationDateYYYYMMDD | 2022-06-01 |
| PublicationDate_xml | – month: 6 year: 2022 text: 20220600 |
| PublicationDecade | 2020 |
| PublicationPlace | Los Angeles, CA |
| PublicationPlace_xml | – name: Los Angeles, CA – name: Thousand Oaks |
| PublicationTitle | Journal of white collar and corporate crime |
| PublicationYear | 2022 |
| Publisher | SAGE Publications Sage Publications Ltd |
| Publisher_xml | – name: SAGE Publications – name: Sage Publications Ltd |
| References | Suchman, Cahill 1996; 21 Wax 1995; 122 Lam, Zhong, Tan 2003; 8 Foote 1978; 7 Griffin, Spillane 2013; 43 Lee, Ermann 1999; 46 Sutherland 1940; 5 Weaver 2016 Fischelis 1938; 46 Ballentine 1981 Braithwaite 1993; 525 Van Der Geest 1982; 6 Jin 2014; 311 Hartog 1993; 37 Tombs 2012; 1 Bohm 1986; 3 Hurt 2009 Rheingold 1968; 56 Whyte 2014; 3 Kidd, Hoffman, Zimmerman, Li, Morgan, Glowe, Botwin, Parekh, Babic, Doust, Stock, Schadt, Dudley 2016; 126 Chakradhar, Khamsi 2017; 23 Rawlinson 2017; 6 Wai, Rindermann 2017; 28 Sobel, Nesbit 2007; 74 Primeaux 2019 Griffin, Miller 2011; 19 Ionescu 2010; 5 Young 1960; 20 Vaughan 1990 Griffin, Spillane 2016; 66 Cavers 1939; 6 Tombs, Whyte 2015; 54 Tombs, Whyte 2020; 1 Boguslaski 1985; 40 Kantor 1976; 66 Moore 2005; 20 Finley 1993; 2 Munsey 1995; 50 bibr41-2631309X20953832 Perrow C. (bibr53-2631309X20953832) 1984 bibr59-2631309X20953832 bibr84-2631309X20953832 bibr3-2631309X20953832 bibr67-2631309X20953832 bibr24-2631309X20953832 bibr25-2631309X20953832 Michalowski R. J. (bibr44-2631309X20953832) 2006 bibr75-2631309X20953832 bibr17-2631309X20953832 bibr15-2631309X20953832 Carreyrou J. (bibr13-2631309X20953832) 2018 bibr58-2631309X20953832 Vaughan D. (bibr76-2631309X20953832) 1983 bibr77-2631309X20953832 bibr42-2631309X20953832 bibr85-2631309X20953832 bibr51-2631309X20953832 bibr2-2631309X20953832 bibr50-2631309X20953832 bibr33-2631309X20953832 Fischelis R. P. (bibr20-2631309X20953832) 1938; 46 bibr27-2631309X20953832 bibr35-2631309X20953832 bibr14-2631309X20953832 bibr56-2631309X20953832 bibr1-2631309X20953832 bibr43-2631309X20953832 Sutherland E. H. (bibr71-2631309X20953832) 1983 bibr66-2631309X20953832 bibr79-2631309X20953832 bibr40-2631309X20953832 Berce J. (bibr6-2631309X20953832) 2001 bibr69-2631309X20953832 bibr4-2631309X20953832 Mintz M. (bibr45-2631309X20953832) 1985 bibr87-2631309X20953832 bibr48-2631309X20953832 bibr74-2631309X20953832 Ballentine C. (bibr5-2631309X20953832) 1981 bibr11-2631309X20953832 bibr38-2631309X20953832 bibr54-2631309X20953832 bibr62-2631309X20953832 bibr8-2631309X20953832 bibr88-2631309X20953832 Kallet A. (bibr34-2631309X20953832) 1933 Hawthorne F. (bibr29-2631309X20953832) 2005 bibr28-2631309X20953832 Primeaux E. (bibr55-2631309X20953832) 2019 bibr64-2631309X20953832 Munsey R. R. (bibr47-2631309X20953832) 1995; 50 bibr80-2631309X20953832 bibr37-2631309X20953832 bibr12-2631309X20953832 bibr63-2631309X20953832 Ionescu L. (bibr32-2631309X20953832) 2010; 5 bibr60-2631309X20953832 Reich R. B. (bibr61-2631309X20953832) 2018 bibr65-2631309X20953832 Braithwaite J. (bibr9-2631309X20953832) 1984 Geis G. (bibr22-2631309X20953832) 1995 bibr81-2631309X20953832 Weaver C. (bibr82-2631309X20953832) 2016 Finley L. M. (bibr19-2631309X20953832) 1993; 2 Knightley P. (bibr39-2631309X20953832) 1979 bibr49-2631309X20953832 Boguslaski M. G. (bibr7-2631309X20953832) 1985; 40 bibr86-2631309X20953832 Clinard M. B. (bibr16-2631309X20953832) 1980 Kauzlarich D. (bibr36-2631309X20953832) 2006 bibr73-2631309X20953832 Southwick K. (bibr68-2631309X20953832) 2003 Moore K. A. (bibr46-2631309X20953832) 2005; 20 Foote S. B. (bibr21-2631309X20953832) 1978; 7 bibr26-2631309X20953832 bibr83-2631309X20953832 bibr23-2631309X20953832 bibr10-2631309X20953832 Vaughan D. (bibr78-2631309X20953832) 1996 bibr18-2631309X20953832 bibr70-2631309X20953832 Hurt C. (bibr31-2631309X20953832) 2009 bibr57-2631309X20953832 Paterick T. J. (bibr52-2631309X20953832) 2008 Tombs S. (bibr72-2631309X20953832) 2012; 1 |
| References_xml | – volume: 46 start-page: 25 issue: 1 year: 1938 end-page: 31 article-title: What is a patent or proprietary medicine? publication-title: The Scientific Monthly contributor: fullname: Fischelis – volume: 20 start-page: 648 year: 1960 end-page: 656 article-title: Patent medicines: An early example of competitive marketing publication-title: The Journal of Economic History contributor: fullname: Young – volume: 3 start-page: 193 issue: 2 year: 1986 end-page: 214 article-title: Crime, criminal and crime control policy myths publication-title: Justice Quarterly contributor: fullname: Bohm – volume: 20 start-page: 1521 issue: 4 year: 2005 end-page: 1552 article-title: Worthless patents publication-title: Berkeley Technology Law Journal contributor: fullname: Moore – volume: 3 start-page: 237 issue: 2 year: 2014 end-page: 246 article-title: Regimes of permission and state-corporate crime publication-title: State Crime Journal contributor: fullname: Whyte – start-page: 947 year: 2009 end-page: 987 article-title: Evil has a new name (and a new narrative): Bernard Madoff publication-title: Michigan State Law Review contributor: fullname: Hurt – volume: 122 start-page: 456 issue: 6 year: 1995 end-page: 461 article-title: Elixirs, diluents, and the passage of the 1938 federal food, drug and cosmetic act publication-title: Annals of Internal Medicine contributor: fullname: Wax – start-page: 18 year: 1981 end-page: 21 article-title: Taste of raspberries, taste of death: The 1937 elixir sulfanilamide incident publication-title: FDA Consumer Magazine contributor: fullname: Ballentine – volume: 1 start-page: 16 issue: 1 year: 2020 end-page: 23 article-title: The Shifting imaginaries of corporate crime publication-title: Journal of White Collar and Corporate Crime contributor: fullname: Whyte – volume: 74 start-page: 71 issue: 1 year: 2007 end-page: 84 article-title: Automobile safety regulation and the incentive to drive recklessly: Evidence from NASCAR publication-title: Southern Economic Journal contributor: fullname: Nesbit – volume: 8 start-page: s2 issue: s1 year: 2003 end-page: s5 article-title: Overview on SARS in Asia and the world publication-title: Respirology contributor: fullname: Tan – volume: 66 start-page: 1202 issue: 12 year: 1976 end-page: 1205 article-title: Upton sinclair and the pure food and drugs act of 1906.” I aimed at the public’s heart and by accident I hit it in the stomach.” publication-title: American Journal of Public Health contributor: fullname: Kantor – start-page: 225 year: 1990 end-page: 257 article-title: Autonomy, interdependence, and social control: NASA and the space shuttle Challenger publication-title: Administrative Science Quarterly contributor: fullname: Vaughan – volume: 19 start-page: 213 issue: 3 year: 2011 end-page: 226 article-title: OxyContin and a regulation deficiency of the pharmaceutical industry: Rethinking state-corporate crime publication-title: Critical Criminology contributor: fullname: Miller – volume: 28 start-page: 127 issue: 1 year: 2017 end-page: 145 article-title: What goes into high educational and occupational achievement? Education, brains, hard work, networks, and other factors publication-title: High Ability Studies contributor: fullname: Rindermann – start-page: 34 year: 2019 article-title: Whistleblower helped dismantle biotech juggernaut Theranos in his ‘zero-strategy’ defense publication-title: Fraud Magazine contributor: fullname: Primeaux – volume: 6 start-page: 197 issue: 4 year: 1982 end-page: 219 article-title: Part 1: The illegal distribution of western medicines in developing countries: Pharmacists, drug Pedlars, injection doctors and others. A bibliographic exploration publication-title: Medical anthropology contributor: fullname: Van Der Geest – volume: 2 start-page: 10 year: 1993 end-page: 16 article-title: Tort reform: An important issue for women publication-title: Circles: Buffalo Women’s Journal of Law and Social Policy contributor: fullname: Finley – volume: 40 start-page: 421 issue: 4 year: 1985 end-page: 444 article-title: Classification and performance standards under the 1976 medical device amendments publication-title: Food, Drug, Cosmetic Law Journal contributor: fullname: Boguslaski – volume: 43 start-page: 164 issue: 2 year: 2013 end-page: 175 article-title: Pharmaceutical regulation failures and changes lessons learned from oxycontin abuse and diversion publication-title: Journal of Drug Issues contributor: fullname: Spillane – volume: 7 start-page: 101 year: 1978 end-page: 135 article-title: Loop and loopholes: Hazardous device regulation under the 1976 medical device amendments to the food, drug and cosmetic act publication-title: Ecology Law Quarterly contributor: fullname: Foote – volume: 56 start-page: 116 year: 1968 end-page: 148 article-title: The MER/29 story—An instance of succesful mass disaster litigation publication-title: California Law Review contributor: fullname: Rheingold – volume: 21 start-page: 679 issue: 3 year: 1996 end-page: 712 article-title: The hired gun as facilitator: Lawyers and the suppression of business disputes in Silicon Valley publication-title: Law & Social Inquiry contributor: fullname: Cahill – volume: 37 start-page: 897 issue: 7 year: 1993 end-page: 904 article-title: Essential and non-essential drugs marketed by the 20 largest European pharmaceutical companies in developing countries publication-title: Social Science & Medicine contributor: fullname: Hartog – volume: 5 start-page: 239 issue: 3 year: 2010 end-page: 244 article-title: Madoff’s fraudulent financial scheme, his decades-long swindle, and the failure of operational risk management publication-title: Economics, Management and Financial Markets contributor: fullname: Ionescu – volume: 126 start-page: 1734 issue: 5 year: 2016 end-page: 1744 article-title: Evaluation of direct-to-consumer low-volume lab tests in healthy adults publication-title: The Journal of clinical investigation contributor: fullname: Dudley – volume: 311 start-page: 435 issue: 4 year: 2014 end-page: 435 article-title: FDA authorization of medical devices publication-title: JAMA contributor: fullname: Jin – year: 2016 article-title: Agony, alarm and anger for people hurt by theranos’s botched blood tests publication-title: The Wall Street Journal contributor: fullname: Weaver – volume: 66 start-page: 421 issue: 4 year: 2016 end-page: 437 article-title: Confounding the process: Forgotten actors and factors in the state-corporate crime paradigm publication-title: Crime, Law and Social Change contributor: fullname: Spillane – volume: 23 start-page: 1114 year: 2017 end-page: 1116 article-title: Angst about exclusivity: The potential cost of incentivizing makers of generic drugs publication-title: Nature Medicine contributor: fullname: Khamsi – volume: 5 start-page: 1 issue: 1 year: 1940 end-page: 12 article-title: White-collar criminality publication-title: American Sociological Review contributor: fullname: Sutherland – volume: 6 start-page: 86 issue: 4 year: 2017 end-page: 99 article-title: Immunity and impunity: Corruption in the state-pharma nexus publication-title: International Journal for Crime, Justice and Social Democracy contributor: fullname: Rawlinson – volume: 54 start-page: 91 year: 2015 end-page: 95 article-title: Challenging the corporation, challenging the state publication-title: The Howard Journal of Criminal Justice contributor: fullname: Whyte – volume: 50 start-page: 163 year: 1995 end-page: 177 article-title: Trends and events in FDA regulation of medical devices over the last fifty years publication-title: Food & Drug Law Journal contributor: fullname: Munsey – volume: 46 start-page: 30 issue: 1 year: 1999 end-page: 47 article-title: Pinto “madness” as a flawed landmark narrative: An organizational and network analysis publication-title: Social Problems contributor: fullname: Ermann – volume: 6 start-page: 2 year: 1939 end-page: 42 article-title: The Food, drug, and cosmetic act of 1938: Its legislative history and its substantive provisions publication-title: Law and Contemporary Problems contributor: fullname: Cavers – volume: 1 start-page: 170 issue: 2 year: 2012 end-page: 195 article-title: State-corporate symbiosis in the production of crime and harm publication-title: State Crime Journal contributor: fullname: Tombs – volume: 525 start-page: 12 issue: 1 year: 1993 end-page: 30 article-title: Transnational regulation of the pharmaceutical industry publication-title: The Annals of the American Academy of Political and Social Science contributor: fullname: Braithwaite – ident: bibr80-2631309X20953832 – volume: 20 start-page: 1521 issue: 4 year: 2005 ident: bibr46-2631309X20953832 publication-title: Berkeley Technology Law Journal contributor: fullname: Moore K. A. – volume-title: At Any cost: Corporate greed, women, and the Dalkon shield year: 1985 ident: bibr45-2631309X20953832 contributor: fullname: Mintz M. – volume: 40 start-page: 421 issue: 4 year: 1985 ident: bibr7-2631309X20953832 publication-title: Food, Drug, Cosmetic Law Journal contributor: fullname: Boguslaski M. G. – ident: bibr10-2631309X20953832 doi: 10.1177/0002716293525001002 – ident: bibr37-2631309X20953832 doi: 10.1172/JCI86318 – ident: bibr64-2631309X20953832 – ident: bibr14-2631309X20953832 doi: 10.2307/1189727 – ident: bibr58-2631309X20953832 – volume: 46 start-page: 25 issue: 1 year: 1938 ident: bibr20-2631309X20953832 publication-title: The Scientific Monthly contributor: fullname: Fischelis R. P. – volume: 7 start-page: 101 year: 1978 ident: bibr21-2631309X20953832 publication-title: Ecology Law Quarterly contributor: fullname: Foote S. B. – volume: 5 start-page: 239 issue: 3 year: 2010 ident: bibr32-2631309X20953832 publication-title: Economics, Management and Financial Markets contributor: fullname: Ionescu L. – ident: bibr67-2631309X20953832 doi: 10.1002/j.2325-8012.2007.tb00827.x – ident: bibr81-2631309X20953832 doi: 10.7326/0003-4819-122-6-199503150-00009 – ident: bibr69-2631309X20953832 doi: 10.1111/j.1747-4469.1996.tb00093.x – start-page: 18 year: 1981 ident: bibr5-2631309X20953832 publication-title: FDA Consumer Magazine contributor: fullname: Ballentine C. – ident: bibr40-2631309X20953832 – volume: 50 start-page: 163 year: 1995 ident: bibr47-2631309X20953832 publication-title: Food & Drug Law Journal contributor: fullname: Munsey R. R. – volume-title: The challenger launch decision: Risky technology, culture and deviance at NASA year: 1996 ident: bibr78-2631309X20953832 contributor: fullname: Vaughan D. – ident: bibr23-2631309X20953832 doi: 10.1007/s10612-010-9113-9 – volume-title: Inside the FDA: The business and politics behind the drugs we take and the food we eat year: 2005 ident: bibr29-2631309X20953832 contributor: fullname: Hawthorne F. – ident: bibr51-2631309X20953832 – volume-title: Everyone else must fail: The unvarnished truth about oracle and Larry Ellison year: 2003 ident: bibr68-2631309X20953832 contributor: fullname: Southwick K. – ident: bibr41-2631309X20953832 doi: 10.1046/j.1440-1843.2003.00516.x – volume-title: Corporate crime in the pharmaceutical industry year: 1984 ident: bibr9-2631309X20953832 contributor: fullname: Braithwaite J. – ident: bibr15-2631309X20953832 doi: 10.1038/nm1017-1114 – ident: bibr86-2631309X20953832 doi: 10.13169/statecrime.3.2.0237 – ident: bibr70-2631309X20953832 doi: 10.2307/2083937 – ident: bibr73-2631309X20953832 doi: 10.1111/hojo.12116 – year: 2016 ident: bibr82-2631309X20953832 publication-title: The Wall Street Journal contributor: fullname: Weaver C. – ident: bibr24-2631309X20953832 doi: 10.1177/0022042612467990 – ident: bibr54-2631309X20953832 – ident: bibr59-2631309X20953832 – ident: bibr4-2631309X20953832 doi: 10.1093/oso/9780195070705.001.0001 – start-page: 34 year: 2019 ident: bibr55-2631309X20953832 publication-title: Fraud Magazine contributor: fullname: Primeaux E. – volume-title: Bad blood: Secrets and lies in a Silicon Valley startup year: 2018 ident: bibr13-2631309X20953832 contributor: fullname: Carreyrou J. – start-page: 947 year: 2009 ident: bibr31-2631309X20953832 publication-title: Michigan State Law Review contributor: fullname: Hurt C. – ident: bibr50-2631309X20953832 – ident: bibr85-2631309X20953832 – ident: bibr77-2631309X20953832 doi: 10.2307/2393390 – ident: bibr63-2631309X20953832 – ident: bibr88-2631309X20953832 doi: 10.1515/9781400860326 – ident: bibr8-2631309X20953832 doi: 10.1080/07418828600088891 – ident: bibr75-2631309X20953832 doi: 10.1080/01459740.1982.9987019 – start-page: 1 volume-title: State-corporate crime: Wrongdoing at the intersection of business and government year: 2006 ident: bibr44-2631309X20953832 contributor: fullname: Michalowski R. J. – ident: bibr3-2631309X20953832 – ident: bibr62-2631309X20953832 doi: 10.2307/3479500 – ident: bibr74-2631309X20953832 doi: 10.1177/2631309X19882641 – ident: bibr66-2631309X20953832 – volume-title: The common good year: 2018 ident: bibr61-2631309X20953832 contributor: fullname: Reich R. B. – ident: bibr11-2631309X20953832 – ident: bibr49-2631309X20953832 – ident: bibr38-2631309X20953832 – ident: bibr27-2631309X20953832 – ident: bibr28-2631309X20953832 doi: 10.1016/0277-9536(93)90144-S – ident: bibr87-2631309X20953832 doi: 10.1017/S0022050700109933 – ident: bibr35-2631309X20953832 doi: 10.2105/AJPH.66.12.1202 – ident: bibr17-2631309X20953832 doi: 10.4337/9781783471102 – volume-title: Suffer the children: The story of Thalidomide year: 1979 ident: bibr39-2631309X20953832 contributor: fullname: Knightley P. – ident: bibr42-2631309X20953832 doi: 10.2307/3097160 – ident: bibr2-2631309X20953832 – ident: bibr25-2631309X20953832 doi: 10.1007/s10611-016-9634-6 – volume-title: Controlling unlawful organizational behavior: Social structure and corporate misconduct year: 1983 ident: bibr76-2631309X20953832 contributor: fullname: Vaughan D. – volume-title: Corporate crime year: 1980 ident: bibr16-2631309X20953832 contributor: fullname: Clinard M. B. – ident: bibr56-2631309X20953832 – ident: bibr60-2631309X20953832 doi: 10.5204/ijcjsd.v6i4.447 – ident: bibr84-2631309X20953832 – ident: bibr48-2631309X20953832 doi: 10.1093/oso/9780195125092.001.0001 – ident: bibr12-2631309X20953832 – start-page: 239 volume-title: State-corporate crime: Wrongdoing at the intersection of business and government year: 2006 ident: bibr36-2631309X20953832 contributor: fullname: Kauzlarich D. – volume-title: Medical informed consent: General considerations for physicians year: 2008 ident: bibr52-2631309X20953832 contributor: fullname: Paterick T. J. – ident: bibr65-2631309X20953832 – ident: bibr26-2631309X20953832 – ident: bibr33-2631309X20953832 doi: 10.1001/jama.2013.286274 – ident: bibr43-2631309X20953832 – ident: bibr1-2631309X20953832 – ident: bibr79-2631309X20953832 doi: 10.1080/13598139.2017.1302874 – volume: 2 start-page: 10 year: 1993 ident: bibr19-2631309X20953832 publication-title: Circles: Buffalo Women’s Journal of Law and Social Policy contributor: fullname: Finley L. M. – volume-title: Normal accidents: Living with high-risk technologies year: 1984 ident: bibr53-2631309X20953832 contributor: fullname: Perrow C. – ident: bibr57-2631309X20953832 – volume: 1 start-page: 170 issue: 2 year: 2012 ident: bibr72-2631309X20953832 publication-title: State Crime Journal contributor: fullname: Tombs S. – ident: bibr18-2631309X20953832 – start-page: 1 volume-title: White-collar crime: Classic and contemporary views year: 1995 ident: bibr22-2631309X20953832 contributor: fullname: Geis G. – volume-title: Time to come of age? Software maturity and the need for a new business model year: 2001 ident: bibr6-2631309X20953832 contributor: fullname: Berce J. – volume-title: 100,000,000 guinea pigs: Dangers in everyday foods year: 1933 ident: bibr34-2631309X20953832 contributor: fullname: Kallet A. – ident: bibr83-2631309X20953832 – volume-title: White collar crime: The uncut version year: 1983 ident: bibr71-2631309X20953832 contributor: fullname: Sutherland E. H. |
| SSID | ssj0002511488 |
| Score | 2.236355 |
| Snippet | Theranos rose to prominence by selling a dream that a company could make blood testing less painful and more effective. The company strove to bring new... |
| SourceID | proquest crossref sage |
| SourceType | Aggregation Database Publisher |
| StartPage | 109 |
| Title | Promises, Deceit and White-Collar Criminality Within the Theranos Scandal |
| URI | https://journals.sagepub.com/doi/full/10.1177/2631309X20953832 https://www.proquest.com/docview/3097444932 |
| Volume | 3 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEF_0-uKLWD-wepZ9kILU1HzsR_axtMopVCtcaX0Kk709LJY7SU9E_3pnsptke7ZQfQlhM0zIzm8nM7M7M4y9tLZGq1u5xCiJDoqENDEO6kRLA3NrQEmgOOTRRzU5ER_O5NnQ3qrNLlnVe_b3tXkl_yNVHEO5UpbsP0i2Z4oDeI_yxStKGK-3kvFxs0Qx-YV-6Kw798fF26Z3CYUEoOn7dpG1fXq--hrONU4p72qxvMTFTbGEixuM1J_Eatd6Vj4Fzlc-xkFqDDAc36HYT6vBPu3tTuDXLKSYhYAC-qL9wadoJ-vamGGuCgpWtb1v8ecRjWVpEavUIkJOHqnHLDXRnzbzudF_K_F2G5kY07tyqohXhiDo1dLYgbhaJ73LNqguohixjf0vx5-P-qAb-VOi7UXaf8qwdf1mnc1VU2XwP6Ijf60VMn3A7gfJ8H2PhU12xy0esrHPsean7mIOjeM7vBtYNt8esfcdTF5zDxKOguQxSHgEEu5BwhEkvAMJDyB5zE7evZ0eTJLQQSOxaBrniYLMgSw11XoVkAMYVNCgcpg5qa0pRZmC1TVRWFUKZ5x0yuZaWyqi5HTxhI0Wy4V7yjhaOFkxlxrdCSF0biGdiUJrB4Aznc3MFnvVTVb13RdKqbJQS359YrfYuJvNKiynywoJtBDC0OMdmuHh0U18nt2W8Dm7NyB9zEar5od7gcbkqt4OEPkD0ftqRQ |
| link.rule.ids | 314,780,784,27924,27925 |
| linkProvider | SAGE Publications |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Promises%2C+Deceit+and+White-Collar+Criminality+Within+the+Theranos+Scandal&rft.jtitle=Journal+of+white+collar+and+corporate+crime&rft.au=Griffin%2C+O.+Hayden&rft.date=2022-06-01&rft.pub=SAGE+Publications&rft.issn=2631-309X&rft.eissn=2631-3103&rft.volume=3&rft.issue=2&rft.spage=109&rft.epage=121&rft_id=info:doi/10.1177%2F2631309X20953832&rft.externalDocID=10.1177_2631309X20953832 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2631-309X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2631-309X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2631-309X&client=summon |